Notably, clinical evidence indicated that DIDO1 variants correlate with hyperandrogenism and central adiposity in females, while solute carrier family 12 member 5 (SLC12A5) mutations heighten T2DM risk in this population [176]. This evidence concerns the gene SLC12A5 and type 2 diabetes mellitus.